Physician

Felix Chiebonam Agbo, M.D

According to 2025 Medicare claims, Felix Agbo, M.D (NPI: 1215145610) practices internal medicine in the Wildwood-The Villages, FL market, with the plurality of this provider's patient population coming from Sumter, FL. This provider's primary affiliated billing organization is SINAI INTERNAL MEDICINE SPECIALISTS (NPI: 1639474364; TIN: 271941226) and primary practice location at 34785-8013. Agbo is affiliated with the 'N HEALTH NETWORK PARTNERS, LLC (ACO ID: D0347), participating under the REACH model.

Agbo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 848 traditional Medicare patients, billed 4,040 HCPCS/CPT codes, and received $248,789 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 13,406 prescription claims across 1,227 beneficiaries totaling $1,231,502 in drug costs, led by Eliquis (Apixaban). DME data shows 68 claims. Open Payments data shows 28 records totaling $750. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $343,383 to $248,789. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,470 to $8,151.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	925	5,505	$343,383
2016	989	5,399	$365,269
2017	1,028	10,146	$338,891
2018	1,131	10,336	$368,323
2019	1,056	21,270	$434,994
2020	841	8,980	$241,525
2021	782	4,884	$306,065
2022	756	4,240	$258,808
2023	847	4,115	$259,142
2024	848	4,040	$248,789

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	850	11,268	$858,239
2016	860	10,825	$833,514
2017	947	11,570	$950,758
2018	972	10,924	$1,001,080
2019	1,079	12,301	$1,069,094
2020	987	12,223	$1,022,566
2021	945	10,842	$1,002,188
2022	964	10,956	$1,086,645
2023	1,035	11,372	$1,213,236
2024	1,227	13,406	$1,231,502

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	52	464	$19,231
2016	102	449	$12,153
2017	52	384	$6,443
2018	56	172	$4,286
2019	67	285	$8,879
2020	46	273	$5,493
2021	17	139	$3,712
2022	13	115	$2,968
2023	N/R	65	$3,442
2024	N/R	68	$5,110

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	101	101	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	653	1,572	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	302	520	$65
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	84	102	$32
96372	Injection of drug or substance under skin or into muscle	79	371	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	139	7,347	$140,176
Ozempic	Semaglutide	83	4,484	$133,187
Rybelsus	Semaglutide	45	3,330	$97,391
Janumet	Sitagliptin Phos/Metformin Hcl	66	4,933	$91,029
Jardiance	Empagliflozin	38	2,853	$52,845

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$4,102
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	17	$522
K0001	Standard wheelchair	Y	N/R	27	$461
A4259	Lancets, per box of 100	N	N/R	12	$24

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$750	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Felix Chiebonam Agbo, M.D?

Tedicare shows public-source Medicare data for Felix Chiebonam Agbo, M.D (NPI 1215145610), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Felix Chiebonam Agbo, M.D have ACO affiliation data?

Felix Chiebonam Agbo, M.D is shown with ACO affiliation data for 'N HEALTH NETWORK PARTNERS, LLC (REACH, ACO ID D0347).

What billing organization is linked to Felix Chiebonam Agbo, M.D?

Felix Chiebonam Agbo, M.D is linked to SINAI INTERNAL MEDICINE SPECIALISTS (billing NPI 1639474364) in the available physician profile data.

Does Felix Chiebonam Agbo, M.D have Open Payments data?

Felix Chiebonam Agbo, M.D has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.